Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Nike
NKE
|
+$631M |
| 2 |
PNC Financial Services
PNC
|
+$614M |
| 3 |
XYZ
Block, Inc.
XYZ
|
+$328M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$275M |
| 5 |
FedEx
FDX
|
+$236M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Meta Platforms (Facebook)
META
|
+$595M |
| 3 |
AbbVie
ABBV
|
+$489M |
| 4 |
Crown Castle
CCI
|
+$326M |
| 5 |
McDonald's
MCD
|
+$325M |
Sector Composition
| 1 | Technology | 20.85% |
| 2 | Consumer Discretionary | 16.57% |
| 3 | Financials | 13.84% |
| 4 | Healthcare | 12.56% |
| 5 | Communication Services | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARMO
401
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| $18.4M | 0.02% |
+493,061
| New | +$18.4M |
|
|
HUD
402
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $18M | 0.02% |
+1,130,861
| New | +$18M |
|
|
EQGP
403
DELISTED
EQGP Holdings, LP
EQGP
| $17.8M | 0.02% |
769,268
-108,496
| -12% | -$2.5M |
|
404
Prestige Consumer Healthcare
PBH
$3.2B
| $17.6M | 0.02% |
523,121
+8,815
| +2% | +$297K |
|
405
Energy Transfer Partners
ET
$60B
| $17.6M | 0.02% |
1,239,144
+413,492
| +50% | +$5.88M |
|
406
Core Laboratories
CLB
$594M
| $17.6M | 0.02% |
162,449
-60,246
| -27% | -$6.52M |
|
|
ETP
407
DELISTED
Energy Transfer Partners, L.P.
ETP
| $17.5M | 0.02% |
1,077,089
-46,404
| -4% | -$753K |
|
408
MGP Ingredients
MGPI
$603M
| $17.2M | 0.02% |
192,085
+13,044
| +7% | +$1.17M |
|
|
KA
409
DELISTED
Kineta, Inc. Common Stock
KA
| $17.2M | 0.02% |
25,870
+3,167
| +14% | +$2.11M |
|
|
EQM
410
DELISTED
EQM Midstream Partners, LP
EQM
| $17M | 0.02% |
287,692
-299
| -0.1% | -$17.6K |
|
411
BioCryst Pharmaceuticals
BCRX
$1.69B
| $16.7M | 0.02% |
3,504,595
+422,360
| +14% | +$2.01M |
|
|
TPGH.U
412
DELISTED
TPG Pace Holdings Corp. Units, each consisting of one Class A ordinary share, $.0001 par value, and
TPGH.U
| $16.5M | 0.02% |
1,575,184
-1,767
| -0.1% | -$18.5K |
|
|
AEUA
413
DELISTED
Anadarko Petroleum Corporation
AEUA
| $16.5M | 0.02% |
552,492
+38,855
| +8% | +$1.16M |
|
414
PagSeguro Digital
PAGS
$2.77B
| $16.4M | 0.02% |
+426,677
| New | +$16.4M |
|
|
MRTX
415
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $16.2M | 0.02% |
528,396
+40,797
| +8% | +$1.25M |
|
416
Entergy
ETR
$40.1B
| $16.1M | 0.02% |
+409,838
| New | +$16.1M |
|
417
Pacira BioSciences
PCRX
$1.21B
| $16M | 0.02% |
+515,132
| New | +$16M |
|
|
ABMD
418
DELISTED
Abiomed Inc
ABMD
| $16M | 0.02% |
55,032
-68,507
| -55% | -$19.9M |
|
419
Independence Realty Trust
IRT
$4.14B
| $15.9M | 0.02% |
1,728,871
+155,436
| +10% | +$1.43M |
|
420
Idexx Laboratories
IDXX
$51.6B
| $15.8M | 0.02% |
+82,349
| New | +$15.8M |
|
421
Agios Pharmaceuticals
AGIO
$2.12B
| $15.6M | 0.02% |
190,752
+24,497
| +15% | +$2M |
|
422
Starbucks
SBUX
$93.6B
| $15.4M | 0.02% |
265,206
+70,836
| +36% | +$4.1M |
|
423
FibroGen
FGEN
$50.3M
| $15M | 0.01% |
13,002
+1,925
| +17% | +$2.22M |
|
424
Monolithic Power Systems
MPWR
$40.2B
| $15M | 0.01% |
129,704
-10,347
| -7% | -$1.2M |
|
425
Warrior Met Coal
HCC
$3.11B
| $15M | 0.01% |
535,517
-351,688
| -40% | -$9.85M |
|